Sang-Mo Kang
Surgical Director of Liver Transplantation · University of California (San Francisco) School of Medicine
Credentials: · · ·
History
- Present
Liver Transplantation · University of California (San Francisco) School of Medicine
- 1999–2001
- 1988–1992
Research
Proceedings of the National Academy of Sciences of the United States of America · 2011 · 702 citations
Nature Medicine · 1997 · First of 7 authors · 392 citations
Systematic review or meta-analysis · The Lancet · 2020 · 387 citations
18 papers
15 papers
11 papers · 2 as a fellow
10 papers · 1 as a fellow
7 papers
7 papers
6 papers
5 papers
Grants
- 2014–2021
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation
National Institute of Allergy and Infectious Diseases · U01
PI · $4.8M · University of California, San Francisco
- 2012–2014
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
National Institute of Allergy and Infectious Diseases · R34
PI · $303.6K · University of California, San Francisco
- 2007–2010
Tolerance Induction Using Modified Dendritic Cells
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $152.6K · University of California, San Francisco
- 2003–2008
Tolerance Induction Using Modified Dendritic Cells
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $609.9K · University of California, San Francisco
Clinical trials
- 2015–2018
Principal investigator · Completed · Phase 1
University of California, San Francisco
- 2014–2019
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Principal investigator · Terminated · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)